Human Health Holdings Limited provided earnings guidance for the year ended 30 June 2022. For the year, the company expected to record a profit attributable to owners of the Company of not less than HKD 350 million as compared to the profit attributable to owners of the Company of approximately HKD 144.5 million for the year ended 30 June 2021. Based on the currently available information, the increase was primarily due to (i) the increase in revenue of general practice services arising from the continuous increase in demand for the preventive, testing, vaccination and outreach services including COVID-19 related services; (ii) the increase in gross profit arising from the increase in revenue; and (iii) offset by the increase in income tax expenses due to the increase in taxable income.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 HKD | -1.96% | 0.00% | -16.67% |
Feb. 27 | Human Health Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Feb. 08 | Human Health Warns of Significant Decline in Fiscal H1 Profit | MT |
1st Jan change | Capi. | |
---|---|---|
-16.67% | 49.46M | |
-14.37% | 85.02B | |
+14.12% | 82.37B | |
+10.49% | 29.29B | |
-10.83% | 17.21B | |
-0.78% | 16.7B | |
+0.45% | 15.5B | |
+3.87% | 12.15B | |
-2.31% | 12.13B | |
+32.62% | 12.12B |
- Stock Market
- Equities
- 1419 Stock
- News Human Health Holdings Limited
- Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022